Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Ovarian Neoplasms

Free Subscription Articles published in Int J Cancer Retrieve available abstracts of 59 articles: HTML format Text format

Single Articles

January 2012
1. HORIUCHI A , Hayashi T, Kikuchi N, Hayashi A, et al
   Hypoxia upregulates ovarian cancer invasiveness via the binding of HIF-1alpha to a hypoxia-induced, methylation free hypoxia response element (HRE) of S100A4 gene.
   Int J Cancer. 2012 Jan 27. doi: 10.1002/ijc.27448.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
2. VERMEIJ R , Leffers N, Hoogeboom BN, Hamming IL, et al
   Potentiation of a p53-SLP vaccine by cyclophosphamide in ovarian cancer, a single arm phase II study.
   Int J Cancer. 2011 Dec 3. doi: 10.1002/ijc.27388.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
3. XU M , Rettig M, Sudlow G, Wang B, et al
   Preclinical evaluation of mab CC188 for ovarian cancer imaging.
   Int J Cancer. 2011 Nov 30. doi: 10.1002/ijc.27380.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
4. MARME F , Hielscher T, Hug S, Bondong S, et al
   Fibroblast growth factor receptor 4 gene (FGFR4) 388Arg allele predicts prolonged survival and platinum sensitivity in advanced ovarian cancer.
   Int J Cancer. 2011 Oct 27. doi: 10.1002/ijc.27329.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
5. YANG HP , Trabert B, Murphy MA, Sherman ME, et al
   Ovarian cancer risk factors by histologic subtypes in the NIH-AARP diet and health study.
   Int J Cancer. 2011 Sep 29. doi: 10.1002/ijc.26469.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. HARRIS HR , Cramer DW, Vitonis AF, Depari M, et al
   Folate, vitamin B(6) , vitamin B(12) , methionine and alcohol intake in relation to ovarian cancer risk.
   Int J Cancer. 2011 Sep 22. doi: 10.1002/ijc.26455.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. LUDVIGSSON JF , West J, Ekbom A, Stephansson O, et al
   Reduced risk of breast, endometrial, and ovarian cancer in women with celiac disease.
   Int J Cancer. 2011 Sep 22. doi: 10.1002/ijc.26454.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. ORENGO AM , Fabbi M, Miglietta L, Andreani C, et al
   Interleukin (IL)-18, a biomarker of human ovarian carcinoma, is predominantly released as biologically inactive precursor.
   Int J Cancer. 2011;129:1116-25.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   August 2011
9. LIN A , Zhang X, Xu HH, Xu DP, et al
   HLA-G expression is associated with metastasis and poor survival in the Balb/c nu/nu murine tumor model with ovarian cancer.
   Int J Cancer. 2011 Aug 19. doi: 10.1002/ijc.26375.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. FUJISAWA T , Joshi BH, Puri RK
    IL-13 regulates cancer invasion and metastasis through IL-13Ralpha2 via ERK/AP-1 pathway in mouse model of human ovarian cancer.
    Int J Cancer. 2011 Aug 19. doi: 10.1002/ijc.26366.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. FEKETE T , Raso E, Pete I, Tegze B, et al
    Meta-analysis of gene expression profiles associated with histological classification and survival in 829 ovarian cancer samples.
    Int J Cancer. 2011 Aug 19. doi: 10.1002/ijc.26364.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
12. FISCHER E , Grunberg J, Cohrs S, Hohn A, et al
    L1-CAM-targeted antibody therapy and (177) Lu-Radioimmunotherapy of disseminated ovarian cancer.
    Int J Cancer. 2011 Jul 27. doi: 10.1002/ijc.26321.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
13. GRAM IT , Lukanova A, Brill I, Braaten T, et al
    Cigarette smoking and risk of histological subtypes of epithelial ovarian cancer in the EPIC cohort study.
    Int J Cancer. 2011 Jun 15. doi: 10.1002/ijc.26235.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
14. BOYERINAS B , Park SM, Murmann AE, Gwin K, et al
    Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of MDR1.
    Int J Cancer. 2011 May 26. doi: 10.1002/ijc.26190.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. THERIAULT BL , Pajovic S, Bernardini MQ, Shaw PA, et al
    Kinesin family member 14: An independent prognostic marker and potential therapeutic target for ovarian cancer.
    Int J Cancer. 2011 May 26. doi: 10.1002/ijc.26189.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
16. LLAURADO M , Abal M, Castellvi J, Cabrera S, et al
    ETV5 transcription factor is overexpressed in ovarian cancer and regulates cell adhesion in ovarian cancer cells.
    Int J Cancer. 2011 Apr 25. doi: 10.1002/ijc.26148.
    PubMed     Text format     Related articles   
    
    
    
    
17. YAO Q , Cao S, Li C, Mengesha A, et al
    Micro-RNA-21 regulates TGF-beta-induced myofibroblast differentiation by targeting PDCD4 in tumor-stroma interaction.
    Int J Cancer. 2011;128:1783-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. DICK MG , Versmold B, Engel C, Meindl A, et al
    Association of death receptor 4 variant (683A>C) with ovarian cancer risk in BRCA1-mutation carriers.
    Int J Cancer. 2011 Apr 11. doi: 10.1002/ijc.26134.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. PARK Y , Kim Y, Lee EY, Lee JH, et al
    Reference ranges for HE4 and CA125 in a large asian population by automated assays and diagnostic performances for ovarian cancer.
    Int J Cancer. 2011 Apr 11. doi: 10.1002/ijc.26129.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. KOSAKA N , Mitsunaga M, Longmire MR, Choyke PL, et al
    Near infrared fluorescence-guided real-time endoscopic detection of peritoneal ovarian cancer nodules using intravenously injected indocyanine green.
    Int J Cancer. 2011 Apr 5. doi: 10.1002/ijc.26113.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
21. ZIOGAS AC , Gavalas NG, Tsiatas M, Tsitsilonis O, et al
    VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals via VEGF receptor type 2.
    Int J Cancer. 2011 Mar 28. doi: 10.1002/ijc.26094.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. GANAPATHY E , Su F, Meriwether D, Devarajan A, et al
    D-4F, an apoA-I mimetic peptide, inhibits proliferation and tumorigenicity of epithelial ovarian cancer cells by upregulating the anti-oxidant enzyme MnSOD.
    Int J Cancer. 2011 Mar 21. doi: 10.1002/ijc.26079.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. HE X , Khurana A, Maguire JL, Chien J, et al
    HtrA1 sensitizes ovarian cancer cells to cisplatin-induced cytotoxicity by targeting XIAP for degradation.
    Int J Cancer. 2011 Mar 8. doi: 10.1002/ijc.26044.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
24. LIBY TA , Spyropoulos P, Lindner HB, Eldridge J, et al
    Akt3 controls VEGF secretion and angiogenesis in ovarian cancer cells.
    Int J Cancer. 2011 Feb 23. doi: 10.1002/ijc.26010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. JACOB F , Goldstein DR, Bovin NV, Pochechueva T, et al
    Serum anti-glycan antibody detection of non-mucinous ovarian cancers by using a printed glycan array.
    Int J Cancer. 2011 Feb 23. doi: 10.1002/ijc.26002.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. LEFFERS N , Vermeij R, Hoogeboom B, Schulze U, et al
    Long-term clinical and immunological effects of p53-SLP(R) vaccine in ovarian cancer patients.
    Int J Cancer. 2011 Feb 16. doi: 10.1002/ijc.25980.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. NAYAK TK , Garmestani K, Baidoo KE, Milenic DE, et al
    PET imaging of tumor angiogenesis in mice with VEGF-A-targeted (86)Y-CHX-A''-DTPA-bevacizumab.
    Int J Cancer. 2011;128:920-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. MAEDA O , Shibata K, Hosono S, Fujiwara S, et al
    Spectrin alphaII and betaII tetramers contribute to platinum anticancer drug resistance in ovarian serous adenocarcinoma.
    Int J Cancer. 2011 Feb 15. doi: 10.1002/ijc.25983.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. KRYCZEK I , Liu S, Roh M, Vatan L, et al
    Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells.
    Int J Cancer. 2011 Feb 3. doi: 10.1002/ijc.25967.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. YAMAMURA S , Matsumura N, Mandai M, Huang Z, et al
    The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer.
    Int J Cancer. 2011 Feb 3. doi: 10.1002/ijc.25961.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. PULIPATI NR , Jin Q, Liu X, Sun B, et al
    Overexpression of the dynein light chain km23-1 in human ovarian carcinoma cells inhibits tumor formation in vivo and causes mitotic delay at prometaphase/metaphase.
    Int J Cancer. 2011 Feb 3. doi: 10.1002/ijc.25954.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
32. JING Y , Lu H, Wu K, Subramanian IV, et al
    Inhibition of ovarian cancer by RGD-P125A-endostatin-Fc fusion proteins.
    Int J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
33. HILDEBRAND JS , Gapstur SM, Feigelson HS, Teras LR, et al
    Postmenopausal hormone use and incident ovarian cancer: Associations differ by regimen.
    Int J Cancer. 2010;127:2928-35.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. GOARD CA , Mather RG, Vinepal B, Clendening JW, et al
    Differential interactions between statins and P-glycoprotein: implications for exploiting statins as anticancer agents.
    Int J Cancer. 2010;127:2936-48.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. WENG D , Song B, Durfee J, Sugiyama V, et al
    Induction of cytotoxic T lymphocytes against ovarian cancer-initiating cells.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. MURPHY MA , Wentzensen N
    Frequency of mismatch repair deficiency in ovarian cancer: A systematic review.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
37. MELIN A , Lundholm C, Malki N, Swahn ML, et al
    Endometriosis as a prognostic factor for cancer survival.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
38. HU J , Nakhla H, Friedman E
    Transient arrest in a quiescent state allows ovarian cancer cells to survive suboptimal growth conditions and is mediated by both MIRK/DYRK1B and p130/RB2.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. YIN M , Xu Y, Lou G, Hou Y, et al
    LAPTM4B overexpression is a novel predictor of epithelial ovarian carcinoma metastasis.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. GREIMEL E , Daghofer F, Edgar P
    Prospective assessment of quality of life in long-term ovarian cancer survivors.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
41. LIS R , Touboul C, Mirshahi P, Ali F, et al
    Tumor associated mesenchymal stem cells protects ovarian cancer cells from hyperthermia through CXCL12.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. WIMBERGER P , Roth C, Pantel K, Kasimir-Bauer S, et al
    Impact of platinum-based chemotherapy on circulating nucleic acid levels, protease activities in blood and disseminated tumor cells in bone marrow of ovarian cancer patients.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
43. GANNON PO , Medelci S, Le Page C, Beaulieu M, et al
    Impact of hemochromatosis gene (HFE) mutations on epithelial ovarian cancer risk and prognosis.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. GUAN Y , Yao H, Zheng Z, Qiu G, et al
    MiR-125b targets BCL3 and suppresses ovarian cancer proliferation.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. NOTARIDOU M , Quaye L, Dafou D, Jones C, et al
    Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
46. HILDEBRAND JS , Gapstur SM, Feigelson HS, Teras LR, et al
    Postmenopausal hormone use and incident ovarian cancer: Associations differ by regimen.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. WEEN MP , Lokman NA, Hoffmann P, Rodgers RJ, et al
    Transforming growth factor beta-induced protein (TGFBIp) secreted by peritoneal cells increases the metastatic potential of ovarian cancer cells.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
48. PASQUET M , Golzio M, Mery E, Rafii A, et al
    Hospicells (ascites-derived stromal cells) promote tumorigenicity and angiogenesis.
    Int J Cancer. 2010;126:2090-101.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
49. LURIE G , Wilkens LR, Thompson PJ, Carney ME, et al
    Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: Pooled analysis in five studies within the Ovarian Cancer Association Consortium.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
50. CHOI KU , Yun JS, Lee IH, Heo SC, et al
    Lysophosphatidic acid-induced expression of periostin in stromal cells: Prognoistic relevance of periostin expression in epithelial ovarian cancer.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. GATES MA , Wolpin BM, Cramer DW, Hankinson SE, et al
    ABO blood group and incidence of epithelial ovarian cancer.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. YEASMIN S , Nakayama K, Rahman MT, Rahman M, et al
    Loss of MKK4 expression in ovarian cancer: A potential role for the epithelial to mesenchymal transition.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. TASEVSKA N , Cross AJ, Dodd KW, Ziegler RG, et al
    No effect of meat, meat cooking preferences, meat mutagens or heme iron on lung cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2010
54. KARBACH J , Gnjatic S, Bender A, Neumann A, et al
    Tumor-reactive CD8+ T-cell responses after vaccination with NY-ESO-1 peptide, CpG 7909 and Montanide ISA-51: association with survival.
    Int J Cancer. 2010;126:909-18.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2010
55. HAYASHI A , Horiuchi A, Kikuchi N, Hayashi T, et al
    Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with down-regulation of E-cadherin.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2009
56. JIN H , Yu Y, Zhang T, Zhou X, et al
    Snail is critical for tumor growth and metastasis of ovarian carcinoma.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2009
57. ZUCO V , Benedetti V, De Cesare M, Zunino F, et al
    Sensitization of ovarian carcinoma cells to the atypical retinoid ST1926 by the histone deacetylase inhibitor, RC307: Enhanced DNA damage response.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2009
58. BROTIN E , Meryet-Figuiere M, Simonin K, Duval RE, et al
    Bcl-x(L) and MCL-1 constitute pertinent targets in ovarian carcinoma and their concomitant inhibition is sufficient to induce apoptosis.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. KOTSOPOULOS J , Hecht JL, Marotti JD, Kelemen LE, et al
    Relationship between dietary and supplemental intake of folate, methionine, vitamin B(6) and folate receptor alpha expression in ovarian tumors.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: